The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice
Piotr Rutkowski, Marcin Ziętek, Bożena Cybulska-Stopa, Joanna Streb, Stanisław Głuszek, Michał Jankowski, Karolina Łopacka-Szatan, Manuela Las‐Jankowska, P. Hudziec, Anna Klimczak, Tomasz Olesiński, Tomasz Świtaj, Hanna Koseła-Paterczyk, Elżbieta Bylina, Czesław Osuch
Topics & Concepts
GiSTPDGFRAMedicineImatinibAdjuvant therapyInternal medicineOncologyImatinib mesylateAdjuvantGastroenterologyStromal tumorExonStromal cellChemotherapyBiologyBiochemistryMyeloid leukemiaGeneGastrointestinal Tumor Research and TreatmentGastrointestinal Bleeding Diagnosis and TreatmentGastrointestinal disorders and treatments